Prevalence and characteristics of subclinical giant cell arteritis in polymyalgia rheumatica

被引:42
|
作者
De Miguel, Eugenio [1 ,9 ]
Macchioni, Pierluigi [2 ]
Conticini, Edoardo [3 ]
Campochiaro, Corrado [4 ]
Karalilova, Rositsa [5 ]
Monti, Sara [6 ]
Ponte, Cristina [7 ]
Klinowski, Giulia [2 ]
Monjo-Henry, Irene [1 ]
Falsetti, Paolo [3 ]
Batalov, Zguro [5 ]
Tomelleri, Alessandro [4 ]
Hocevar, Alojzija [8 ]
机构
[1] Hosp Univ La Paz, Rheumatol Dept, Madrid, Spain
[2] IRCCS S Maria Nuova, Dept Rheumatol, Reggio Emilia, Italy
[3] Univ Siena, Dept Med Surg & Neurosci, Rheumatol Unit, Siena, Italy
[4] Ist Sci San Raffaele, Rheumatol Dept, Unit Immunol, Allergy & Rare Dis UnIRAR, Milan, Italy
[5] Univ Hosp Kaspela, Med Univ Plovdiv, Rheumatol Dept, Plovdiv, Bulgaria
[6] Univ Pavia, IRCCS Policlin S Matteo Fdn, Dept Rheumatol, Pavia, Italy
[7] Ctr Hosp Univ Lisboa Norte EPE, Hosp Santa Maria, Rheumatol Dept, Lisbon, Portugal
[8] Univ Med Ctr Ljubljana, Dept Rheumatol, Ljubljana, Slovenia
[9] Hosp Univ La Paz, Rheumatol Dept, P Castellana 261, Madrid 28046, Spain
关键词
PMR; GCA; vasculitis; epidemiology; ultrasonography; COLOR DOPPLER SONOGRAPHY; TEMPORAL ARTERITIS; ULTRASOUND; DIAGNOSIS; ATHEROSCLEROSIS; INVOLVEMENT;
D O I
10.1093/rheumatology/kead189
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective The main objective of this study was to analyse the prevalence and characteristics of subclinical GCA in patients with PMR. Methods This was a cross-sectional multicentre international study of consecutive patients with newly diagnosed PMR without symptoms or signs suggestive of GCA. All patients underwent US of the temporal superficial, common carotid, subclavian and axillary arteries. Patients with halo signs in at least one examined artery were considered to have subclinical GCA. The clinical, demographic and laboratory characteristics of the PMR group without subclinical vasculitis were compared with subclinical GCA, and the pattern of vessel involvement was compared with that of a classical single-centre GCA cohort. Results We included 346 PMR patients, 267 (77.2%) without subclinical GCA and 79 (22.8%) with subclinical GCA. The PMR patients with subclinical GCA were significantly older, had a longer duration of morning stiffness and more frequently reported hip pain than PMR without subclinical GCA. PMR with subclinical GCA showed a predominant extracranial large vessel pattern of vasculitic involvement compared with classical GCA, where the cranial phenotype predominated. The patients with PMR in the classical GCA group showed a pattern of vessel involvement similar to classical GCA without PMR but different from PMR with subclinical involvement. Conclusion More than a fifth of the pure PMR patients had US findings consistent with subclinical GCA. This specific subset of patients showed a predilection for extracranial artery involvement. The optimal screening strategy to assess the presence of vasculitis in PMR remains to be determined.
引用
收藏
页码:158 / 164
页数:7
相关论文
共 50 条
  • [1] Giant Cell Arteritis and Polymyalgia Rheumatica: an Update
    Gonzalez-Gay, Miguel A.
    Pina, Trinitario
    CURRENT RHEUMATOLOGY REPORTS, 2015, 17 (02)
  • [2] The spectrum of giant cell arteritis and polymyalgia rheumatica: a longitudinal prospective study to assess for subclinical giant cell arteritis in new onset polymyalgia rheumatica
    El Miedany, Yasser
    El Gaafary, Maha
    Toth, Mathias
    Bahlas, Sami
    Hassan, Waleed
    Mahran, Safaa
    Abu-Zaid, Mohammed Hassan
    El Miedany, Ali
    Elwakil, Walaa
    EGYPTIAN RHEUMATOLOGY AND REHABILITATION, 2025, 52 (01)
  • [3] DIFFERENCES IN CLINICAL AND ULTRASOUND CHARACTERISTICS OF POLYMYALGIA RHEUMATICA PATIENTS WITH SUBCLINICAL GIANT CELL ARTERITIS COMPARED TO THOSE WITH CLINICAL GIANT CELL ARTERITIS
    Cowley, S.
    Kirby, C.
    Harkins, P.
    Mullan, R.
    Conway, R.
    Murphy, G.
    Kane, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 645 - 645
  • [4] Prevalence of ischemic complications in patients with giant cell arteritis presenting with apparently isolated polymyalgia rheumatica
    Narvaez, Javier
    Estrada, Paula
    Lopez-Vives, Laura
    Ricse, Milagros
    Zacarias, Andrea
    Heredia, Sergi
    Gomez-Vaquero, Carmen
    Nolla, Joan M.
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2015, 45 (03) : 328 - 333
  • [5] Contemporary prevalence estimates for giant cell arteritis and polymyalgia rheumatica, 2015
    Crowson, Cynthia S.
    Matteson, Eric L.
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2017, 47 (02) : 253 - 256
  • [6] Subclinical giant cell arteritis increases the risk of relapse in polymyalgia rheumatica
    De Miguel, Eugenio
    Karalilova, Rositsa
    Macchioni, Pierluigi
    Ponte, Cristina
    Conticini, Edoardo
    Cowley, Sharon
    Tomelleri, Alessandro
    Monti, Sara
    Monjo, Irene
    Batalov, Zguro
    Klinowski, Giulia
    Falsetti, Paolo
    Kane, David J.
    Campochiaro, Corrado
    Hocevar, Alojzija
    ANNALS OF THE RHEUMATIC DISEASES, 2024, 83 (03) : 335 - 341
  • [7] Predictive Factors of Giant Cell Arteritis in Polymyalgia Rheumatica Patients
    Ramon, Andre
    Greigert, Helene
    Ornetti, Paul
    Maillefert, Jean-Francis
    Bonnotte, Bernard
    Samson, Maxime
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (24)
  • [8] Incidence and prevalence of giant cell arteritis and polymyalgia rheumatica: A systematic literature review
    Sharma, Ankita
    Mohammad, Aladdin J.
    Turesson, Carl
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2020, 50 (05) : 1040 - 1048
  • [9] The prevalence of giant cell arteritis and polymyalgia rheumatica in a UK primary care population
    Yates, Max
    Graham, Karly
    Watts, Richard Arthur
    MacGregor, Alexander James
    BMC MUSCULOSKELETAL DISORDERS, 2016, 17
  • [10] Update on the Treatment of Giant Cell Arteritis and Polymyalgia Rheumatica
    El Chami, Sarah
    Springer, Jason M.
    MEDICAL CLINICS OF NORTH AMERICA, 2021, 105 (02) : 311 - 324